| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |